{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:58Z","timestamp":1792791478511,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients undergoing mechanical ventilation (MV) for COVID-19 exhibit an increased risk of ventilator-associated pneumonia (VAP). The occurrence of lung abscesses following VAP in these patients has been poorly studied. We aimed to describe the incidence, characteristics, risk factors and prognosis of lung abscesses complicating VAP after COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted an observational, retrospective study in three French intensive care units. Patients admitted for acute respiratory failure with a confirmed SARS-CoV-2 PCR and requiring MV for more than 48\u00a0h were included.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 507 patients included, 326 (64%) had a documented VAP. Of these, 23 (7%) developed a lung abscess. Enterobacterales (15\/23, 65%) were the main documentation, followed by non-fermenting Gram-negative bacilli (10\/23, 43%) and Gram-positive cocci (8\/23, 35%). Lung abscesses were mainly plurimicrobial (15\/23, 65%). In multivariate analysis, a plurimicrobial 1st VAP episode (OR (95% CI) 2.93 (1.16\u20137.51); p\u2009=\u20090.02) and the use of hydrocortisone (OR (95% CI) 4.86 (1.95\u201312.1); p\u2009=\u20090.001) were associated with lung abscess development. Intensive care unit (ICU) mortality of patients with lung abscesses reached 52%, but was not significantly higher than for patients with VAP but no lung abscess. Patients with lung abscesses had reduced ventilator-free days at day 60, a longer duration of MV and ICU stay than patients with VAP but no lung abscess (respectively, 0 (0\u20133) vs. 16 (0\u201342) days; p\u2009&lt;\u20090.001, 49 (32\u201373) vs. 25 (11\u201341) days; p\u2009&lt;\u20090.001, 52 (36\u201377) vs. 28 (16\u201347) days; p\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Lung abscessing pneumonia is not uncommon among COVID-19 patients developing VAP. A plurimicrobial first VAP episode and the use of hydrocortisone are independently associated with this complication. In COVID-19 patients with persistent VAP, a chest CT scan investigating the evolution toward lung abscess should be considered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-023-04660-x","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T15:01:41Z","timestamp":1696431701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lung abscess following ventilator-associated pneumonia during COVID-19: a retrospective multicenter cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"S.","family":"Hraiech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ladjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Guervilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hyvernat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Papazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Forel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dellamonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gragueb-Chatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"4660_CR1","unstructured":"ref WHO Coronavirus (COVID-19) Dashboard [Internet]. Disponible sur: https:\/\/covid19.who.int\/data"},{"key":"4660_CR2","doi-asserted-by":"crossref","unstructured":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021;47(1):60\u201373.","DOI":"10.1007\/s00134-020-06294-x"},{"issue":"2","key":"4660_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00134-020-06323-9","volume":"47","author":"A Rouz\u00e9","year":"2021","unstructured":"Rouz\u00e9 A, Martin-Loeches I, Povoa P, Makris D, Artigas A, Bouchereau M, et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021;47(2):188\u201398.","journal-title":"Intensive Care Med"},{"issue":"1","key":"4660_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13613-020-00775-4","volume":"10","author":"CE Luyt","year":"2020","unstructured":"Luyt CE, Sahnoun T, Gautier M, Vidal P, Burrel S, Pineton de Chambrun M, et al. Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Ann Intensive Care. 2020;10(1):158.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"4660_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120\u20138.","journal-title":"N Engl J Med"},{"issue":"9","key":"4660_CR6","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00134-020-06127-x","volume":"46","author":"R Jeannet","year":"2020","unstructured":"Jeannet R, Daix T, Formento R, Feuillard J, Fran\u00e7ois B. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression. Intensive Care Med. 2020;46(9):1769\u201371.","journal-title":"Intensive Care Med"},{"issue":"1","key":"4660_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13054-021-03460-5","volume":"25","author":"M Maes","year":"2021","unstructured":"Maes M, Higginson E, Pereira-Dias J, Curran MD, Parmar S, Khokhar F, et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care. 2021;25(1):25.","journal-title":"Crit Care"},{"issue":"7","key":"4660_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jiac.2023.02.005","volume":"29","author":"K Umamoto","year":"2023","unstructured":"Umamoto K, Horiba M. Lung abscess as a secondary infection of COVID-19: a case report and literature review. J Infect Chemother. 2023;29(7):700\u20132.","journal-title":"J Infect Chemother"},{"issue":"1","key":"4660_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13054-021-03493-w","volume":"25","author":"G Blonz","year":"2021","unstructured":"Blonz G, Kouatchet A, Chudeau N, Pontis E, Lorber J, Lemeur A, et al. Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region. Crit Care. 2021;25(1):72.","journal-title":"Crit Care"},{"issue":"5","key":"4660_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000919","volume":"5","author":"S Utsumi","year":"2023","unstructured":"Utsumi S, Ohshimo S, Ishii J, Nishikimi M, Shime N. Lung abscess and pyothorax in critically ill COVID-19 patients: a single-center retrospective study. Crit Care Explor. 2023;5(5): e0919.","journal-title":"Crit Care Explor"},{"issue":"7","key":"4660_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000482","volume":"3","author":"V Beaucot\u00e9","year":"2021","unstructured":"Beaucot\u00e9 V, Plantef\u00e8ve G, Tirolien JA, Desaint P, Fraiss\u00e9 M, Contou D. Lung abscess in critically ill coronavirus disease 2019 patients with ventilator-associated pneumonia: a French monocenter retrospective study. Crit Care Explor. 2021;3(7): e0482.","journal-title":"Crit Care Explor"},{"issue":"24","key":"4660_CR12","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA. 1993;270(24):2957\u201363.","journal-title":"JAMA"},{"key":"4660_CR13","doi-asserted-by":"crossref","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, de Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22(7):707\u201110.","DOI":"10.1007\/BF01709751"},{"issue":"6","key":"4660_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infectious Diseases. 2020;71(6):1367\u201376.","journal-title":"Clin Infectious Diseases."},{"issue":"6","key":"4660_CR15","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149\u201362.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4660_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.accpm.2017.11.006","volume":"37","author":"M Leone","year":"2018","unstructured":"Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, et al. Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med. 2018;37(1):83\u201398.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"5","key":"4660_CR17","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-111.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4660_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/MCC.0000000000000908","volume":"28","author":"J Fumagalli","year":"2022","unstructured":"Fumagalli J, Panigada M, Klompas M, Berra L. Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients. Curr Opin Crit Care. 2022;28(1):74\u201382.","journal-title":"Curr Opin Crit Care"},{"issue":"2","key":"4660_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.anaerobe.2011.12.004","volume":"18","author":"JG Bartlett","year":"2012","unstructured":"Bartlett JG. Anaerobic bacterial infection of the lung. Anaerobe. 2012;18(2):235\u20139.","journal-title":"Anaerobe"},{"issue":"23","key":"4660_CR20","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.3390\/jcm11237097","volume":"11","author":"I Gragueb-Chatti","year":"2022","unstructured":"Gragueb-Chatti I, Hyvernat H, Leone M, Agard G, Peres N, Guervilly C, et al. Incidence, outcomes and risk factors of recurrent ventilator associated pneumonia in COVID-19 patients: a retrospective multicenter study. J Clin Med. 2022;11(23):7097.","journal-title":"J Clin Med"},{"issue":"2","key":"4660_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1055\/s-0041-1722992","volume":"42","author":"SA Berkman","year":"2021","unstructured":"Berkman SA, Tapson VF. COVID-19 and its implications for thrombosis and anticoagulation. Semin Respir Crit Care Med. 2021;42(2):316\u201326.","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"4660_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/rheumatology\/ker223","volume":"51","author":"VR Lang","year":"2012","unstructured":"Lang VR, Englbrecht M, Rech J, N\u00fcsslein H, Manger K, Schuch F, et al. Risk of infections in rheumatoid arthritis patients treated with tocilizumab. Rheumatology. 2012;51(5):852\u20137.","journal-title":"Rheumatology"},{"issue":"4","key":"4660_CR23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/annrheumdis-2018-214367","volume":"78","author":"A Pawar","year":"2019","unstructured":"Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, et al. Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study. Ann Rheum Dis. 2019;78(4):456\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4660_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","volume":"181","author":"S Gupta","year":"2021","unstructured":"Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, et al. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med. 2021;181(1):41\u201351.","journal-title":"JAMA Intern Med"},{"issue":"16","key":"4660_CR25","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","volume":"384","author":"IO Rosas","year":"2021","unstructured":"Rosas IO, Br\u00e4u N, Waters M, Go RC, Hunter BD, Bhagani S, et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N Engl J Med. 2021;384(16):1503\u201316.","journal-title":"N Engl J Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04660-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04660-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04660-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T11:04:02Z","timestamp":1700478242000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04660-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4660"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04660-x","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"9 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients and their relatives were informed of the possibility to use their medical data for retrospective studies and their opposition was researched. The study was approved by the French Intensive Care Society Ethics Committee (Commission d\u2019Ethique de la SRLF, reference CE SRLF 21\u201006) which waived the need for written consent according to the French legislation. The study was also declared and approved by the \u201cPortail d\u2019Acc\u00e8s aux Donn\u00e9es de Sante\u0301, Assistance Publique-H\u00f4pitaux de Marseille\u201d (Registration number PADS20\u2010366).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"385"}}